Mucopolysaccharidosis type IIIB (MPS IIIB) masquerading as a behavioural disorder

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Brady, Jacqueline ^a   Trehan, Aditi ^a   Landis, Dennis ^a   Toro, Camilo ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGGRESSION; APATHY; APRAXIA; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE COURSE; FEMALE; HEPATOMEGALY; HUMAN; HYPERREFLEXIA; INTELLECTUAL IMPAIRMENT; IRRITABILITY; JOINT LAXITY; MENTAL DISEASE; MUTENESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SANFILIPPO SYNDROME;

EID: 84878974507     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-009592     Document Type: Article

References (19)

1. Costello EJ, Mustillo S, Erkanli A, et al. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003;60:837-44. (Pubitemid 36960915)
2. Wichstrom L, Berg-Nielsen TS, Angold A, et al. Prevalence of psychiatric disorders in preschoolers. J Child Psychol Psychiatry 2012;53:695-705.
3. Sedel F, Baumann N, Turpin JC, et al. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis 2007;30:631-41. (Pubitemid 47559874)
4. Staretz-Chacham O, Choi JH, Wakabayashi K, et al. Psychiatric and behavioural manifestations of lysosomal storage disorders. Am J Med Genet B Neuropsychiatr Genet 2010;153B:1253-65.
5. McNeill A, Birchall D, Hayflick SJ, et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008;70:1614-19. (Pubitemid 351620317)
6. Kruer MC, Boddaert N, Schneider SA, et al. Neuroimaging features of neurodegeneration with brain iron accumulation. Am J Neuroradiol 2012;33:407-14.
7. Harris ZL, Takahashi Y, Miyajima H, et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995;92:2539-43.
8. Patel BN, Dunn RJ, David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 2000;275:4305-10. (Pubitemid 30094671)
9. Miyajima H, Takahashi Y, Kono S. Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 2003;16:205-13. (Pubitemid 36140230)
10. Coutinho M, Lacerda L, Alves S. Glycosaminoglycan storage disorders: a review. Biochem Res Int 2012;2012:471325.
11. Weber B, Guo XH, Kleijer WJ, et al. Sanfilippo type B syndrome (mucopolysaccharidosis IIIB): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet 1999;7:34-44. (Pubitemid 29179030)
12. Tessitore A, Villani G, Di Domenico C, et al. Molecular defects in the alpha-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients. Hum Genet 2000;107:568-76. (Pubitemid 32010958)
13. Valstar MJ, Bruggenwirth HT, Olmer R, et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherited Metab Dis 2010;33:759-67.
14. Schipper HM. Neurodegeneration with brain iron accumulation- clinical syndromes and neuroimaging. Biochim Biophys Acta 2012;1822:350-60.
15. Villani GRD, Gargiulo N, Faraonio R, et al. Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. J Neurosci Res 2007;85:612-22.
16. Winder-Rhodes SE, Garcia-Reitbock P, Ban M, et al. Genetic and pathological links between Parkinson's Disease and the lysosomal disorder Sanfilippo Syndrome. Mov Disord 2012;27:312-15.
17. Zafeiriou DI, Savvopoulou-Augoustidou PA, Sewell A, et al. Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B). Brain Dev 2001;23:385-89. (Pubitemid 32913055)
18. Fu H, Samulski RJ, McCown TJ, et al. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mol Ther 2002;5:42-9. (Pubitemid 34110479)
19. Heldermon CD, Ohlemiller KK, Herzog ED, et al. Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB. Mol Ther 2010;18:873-80.